Lila Am 1

1. Analysis of the course of immune-mediated inflammatory rheumatic diseases after COVID-19: flare frequency and prognostic determinants
2. Forecasting index of unfavorable outcomes of systemic lupus erythematosus
3. Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
4. CLINICAL MANIFESTATIONS OF DAMAGE TO THE CARDIOVASCULAR SYSTEM AND PREDICTORS OF POOR PROGNOSIS OF TAKAYASU ARTERITIS IN KYRGYZ PATIENTS
5. Depletion-restitution therapy of autoimmune rheumatic diseases. Part 2. Perspectives on bispecific antibodies
6. Eurasian recommendations for the diagnosis and treatment of primary osteoarthritis (2025). League of Eurasian Rheumatologists (LEAR)
7. Multimorbidity in osteoarthritis and pleiotropic effects of slow-acting symptomatic drugs. Resolution of the multidisciplinary International Expert Council
8. Objective assessment of the damaging effect of glucocorticoids (toxicity index) in patients with systemic lupus erythematosus
9. International declaration of adherence to treatment 2023 («omsk declaration»): presentation for russian readers
10. Shared features of pathogenetic aspects, autoimmunity and pharmacotherapy in coronavirus infection (COVID-19) and immunoinflammatory rheumatic diseases
1